SCHEMBL24979321

SCHEMBL24979321

CC(C)COC(=O)CN1CCN(c2ccc(B3OC(C)(C)C(C)(C)O3)cc2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.46
AAK1 Q2M2I8 1/20 0.36
POLB P06746 2/20 0.36
GAA P10253 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
USP2 O75604 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
GFER P55789 2/20 0.34
LIPG Q9Y5X9 2/20 0.34
HTT P42858 2/20 0.34
MAPT P10636 3/20 0.34
ALDH1A1 P00352 3/20 0.34
S1PR1 P21453 1/20 0.34
F2 P00734 1/20 0.34
F11 P03951 1/20 0.34
PRSS1 P07477 1/20 0.34
PRSS2 P07478 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10197505 0.85 SMN1; SMN2 (0.45) SMN1; SMN2KMT2AMEN1TSHRGFER
SCHEMBL29429852 0.84 MAPT (0.43) SMN1; SMN2POLBKMT2AMEN1TSHR
SCHEMBL25219317 0.82 SMN1; SMN2 (0.43) SMN1; SMN2AAK1GAAKMT2AMEN1
SCHEMBL22636528 0.81 S1PR1 (0.50) SMN1; SMN2POLBUSP2ALOX15TSHR
SCHEMBL24506432 0.79 KDM4E (0.41) SMN1; SMN2GAAKMT2AMEN1GFER
SCHEMBL10267432 0.76 KMT2A (0.46) POLBGAAKMT2AMEN1TSHR
SCHEMBL23551869 0.76 CYP3A4 (0.46) SMN1; SMN2KMT2AMEN1USP2ALOX15
SCHEMBL25251960 0.76 MAPT (0.41) SMN1; SMN2AAK1GAAKMT2AMEN1
SCHEMBL1240538 0.75 LIPG (0.47) AAK1LIPGF2F11PRSS1
SCHEMBL20294734 0.75 USP30 (0.39) SMN1; SMN2AAK1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230022524-A1 HETEROBIFUNCTIONAL COMPOUNDS AS DEGRADERS OF HPK1 ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230022524-A1 HETEROBIFUNCTIONAL COMPOUNDS AS DEGRADERS OF HPK1 HIPK1, MCL1, HYPK SMN1; SMN2 3222/4885AAK1 35/4885POLB 1913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.